MedX Health Corp (TSXV:MDX)
Canada · Delayed Price · Currency is CAD 0.0500
0.00 (0.00%)
Aug 21, 2026, 12:11 PM EST
MedX Health Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.54 | 0.47 | 0.49 | 0.46 | 0.51 | 0.56 | |
Revenue Growth | 9.29% | -3.36% | 7.37% | -10.68% | -9.32% | 6.23% |
Cost of Revenue | 0.58 | 0.53 | 0.3 | 0.27 | 0.27 | 0.29 |
Gross Profit | -0.04 | -0.05 | 0.19 | 0.19 | 0.24 | 0.27 |
Selling, General & Admin | 3.45 | 3.74 | 1.97 | 2.63 | 3.43 | 3.84 |
Research & Development | 0.52 | 0.5 | 0.53 | 0.59 | 0.68 | 1 |
Operating Expenses | 3.97 | 4.24 | 2.5 | 3.21 | 4.11 | 4.84 |
Operating Income | -4.01 | -4.29 | -2.3 | -3.03 | -3.87 | -4.56 |
Interest Expense | -1.67 | -1.76 | -1.35 | -2.15 | -1.27 | -0.78 |
Currency Exchange Gain (Loss) | - | - | - | - | 0 | -0.01 |
EBT Excluding Unusual Items | -5.68 | -6.05 | -3.65 | -5.18 | -5.13 | -5.35 |
Gain (Loss) on Sale of Assets | - | - | - | 0.6 | - | - |
Other Unusual Items | -0.24 | -0.24 | - | - | - | 0.02 |
Pretax Income | -5.92 | -6.29 | -3.65 | -4.58 | -5.13 | -5.32 |
Net Income | -5.92 | -6.29 | -3.65 | -4.58 | -5.13 | -5.32 |
Net Income to Common | -5.92 | -6.29 | -3.65 | -4.58 | -5.13 | -5.32 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 310 | 296 | 267 | 197 | 184 | 180 |
Shares Outstanding (Diluted) | 310 | 296 | 267 | 197 | 184 | 180 |
Shares Change | 15.22% | 11.12% | 35.55% | 7.09% | 1.98% | 8.18% |
EPS (Basic) | -0.02 | -0.02 | -0.01 | -0.02 | -0.03 | -0.03 |
EPS (Diluted) | -0.02 | -0.02 | -0.01 | -0.02 | -0.03 | -0.03 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -4.05 | -3.73 | -2.51 | -3.42 | -2.8 | -4.53 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | -0.03 |
Gross Margin | -7.37% | -11.51% | 39.66% | 40.70% | 46.99% | 48.54% |
Operating Margin | -741.98% | -906.90% | -470.44% | -663.99% | -757.61% | -810.29% |
Profit Margin | -1095.80% | -1329.15% | -745.96% | -1004.31% | -1005.41% | -945.40% |
Free Cash Flow Margin | -749.90% | -788.56% | -512.70% | -750.32% | -548.53% | -805.04% |
EBITDA | -4.01 | -4.29 | -2.3 | -3.02 | -3.86 | -4.55 |
D&A For EBITDA | -0.01 | 0 | 0 | 0.01 | 0.01 | 0.01 |
EBIT | -4.01 | -4.29 | -2.3 | -3.03 | -3.87 | -4.56 |